nodes	percent_of_prediction	percent_of_DWPC	metapath
Pomalidomide—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.174	0.426	CbGbCtD
Pomalidomide—ABCB1—Colchicine—primary biliary cirrhosis	0.147	0.359	CbGbCtD
Pomalidomide—CYP3A4—Colchicine—primary biliary cirrhosis	0.088	0.215	CbGbCtD
Pomalidomide—Lenalidomide—CDH5—primary biliary cirrhosis	0.0205	0.813	CrCbGaD
Pomalidomide—Interstitial lung disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.00643	0.0202	CcSEcCtD
Pomalidomide—Interstitial lung disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.00643	0.0202	CcSEcCtD
Pomalidomide—Bone pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00475	0.0149	CcSEcCtD
Pomalidomide—Bone pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00475	0.0149	CcSEcCtD
Pomalidomide—Thalidomide—NFKB1—primary biliary cirrhosis	0.00472	0.187	CrCbGaD
Pomalidomide—Musculoskeletal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00461	0.0145	CcSEcCtD
Pomalidomide—Musculoskeletal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00461	0.0145	CcSEcCtD
Pomalidomide—Cardiac failure congestive—Ursodeoxycholic acid—primary biliary cirrhosis	0.00364	0.0115	CcSEcCtD
Pomalidomide—Cardiac failure congestive—Chenodeoxycholic acid—primary biliary cirrhosis	0.00364	0.0115	CcSEcCtD
Pomalidomide—Atrial fibrillation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00349	0.011	CcSEcCtD
Pomalidomide—Atrial fibrillation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00349	0.011	CcSEcCtD
Pomalidomide—Blood creatinine increased—Colchicine—primary biliary cirrhosis	0.00345	0.0108	CcSEcCtD
Pomalidomide—Dehydration—Colchicine—primary biliary cirrhosis	0.00342	0.0108	CcSEcCtD
Pomalidomide—Muscular weakness—Colchicine—primary biliary cirrhosis	0.00324	0.0102	CcSEcCtD
Pomalidomide—Alanine aminotransferase increased—Colchicine—primary biliary cirrhosis	0.00324	0.0102	CcSEcCtD
Pomalidomide—Blood creatinine increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.0031	0.00974	CcSEcCtD
Pomalidomide—Blood creatinine increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.0031	0.00974	CcSEcCtD
Pomalidomide—Dehydration—Chenodeoxycholic acid—primary biliary cirrhosis	0.00307	0.00967	CcSEcCtD
Pomalidomide—Dehydration—Ursodeoxycholic acid—primary biliary cirrhosis	0.00307	0.00967	CcSEcCtD
Pomalidomide—Pancytopenia—Colchicine—primary biliary cirrhosis	0.00302	0.00949	CcSEcCtD
Pomalidomide—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00299	0.00939	CcSEcCtD
Pomalidomide—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00299	0.00939	CcSEcCtD
Pomalidomide—Neutropenia—Colchicine—primary biliary cirrhosis	0.00297	0.00935	CcSEcCtD
Pomalidomide—Alanine aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00291	0.00917	CcSEcCtD
Pomalidomide—Alanine aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00291	0.00917	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Colchicine—primary biliary cirrhosis	0.00278	0.00874	CcSEcCtD
Pomalidomide—Bronchitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00275	0.00864	CcSEcCtD
Pomalidomide—Bronchitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00275	0.00864	CcSEcCtD
Pomalidomide—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00265	0.00835	CcSEcCtD
Pomalidomide—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00265	0.00835	CcSEcCtD
Pomalidomide—Weight increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.0026	0.00817	CcSEcCtD
Pomalidomide—Weight increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.0026	0.00817	CcSEcCtD
Pomalidomide—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00258	0.00813	CcSEcCtD
Pomalidomide—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00258	0.00813	CcSEcCtD
Pomalidomide—Pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00256	0.00806	CcSEcCtD
Pomalidomide—Pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00256	0.00806	CcSEcCtD
Pomalidomide—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00255	0.00801	CcSEcCtD
Pomalidomide—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00255	0.00801	CcSEcCtD
Pomalidomide—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.00255	0.00801	CcSEcCtD
Pomalidomide—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.00255	0.00801	CcSEcCtD
Pomalidomide—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.0025	0.00787	CcSEcCtD
Pomalidomide—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.0025	0.00787	CcSEcCtD
Pomalidomide—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00248	0.00779	CcSEcCtD
Pomalidomide—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00248	0.00779	CcSEcCtD
Pomalidomide—Hepatobiliary disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.00241	0.00757	CcSEcCtD
Pomalidomide—Hepatobiliary disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.00241	0.00757	CcSEcCtD
Pomalidomide—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.0024	0.00755	CcSEcCtD
Pomalidomide—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.0024	0.00755	CcSEcCtD
Pomalidomide—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.00229	0.00721	CcSEcCtD
Pomalidomide—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00226	0.0071	CcSEcCtD
Pomalidomide—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00226	0.0071	CcSEcCtD
Pomalidomide—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.00225	0.00708	CcSEcCtD
Pomalidomide—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.00225	0.00708	CcSEcCtD
Pomalidomide—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00225	0.00707	CcSEcCtD
Pomalidomide—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00225	0.00707	CcSEcCtD
Pomalidomide—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00224	0.00705	CcSEcCtD
Pomalidomide—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00224	0.00705	CcSEcCtD
Pomalidomide—Malnutrition—Colchicine—primary biliary cirrhosis	0.00222	0.00697	CcSEcCtD
Pomalidomide—Muscle spasms—Colchicine—primary biliary cirrhosis	0.00213	0.0067	CcSEcCtD
Pomalidomide—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00212	0.00667	CcSEcCtD
Pomalidomide—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00212	0.00667	CcSEcCtD
Pomalidomide—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.00207	0.00652	CcSEcCtD
Pomalidomide—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.00207	0.00652	CcSEcCtD
Pomalidomide—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00206	0.00648	CcSEcCtD
Pomalidomide—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00206	0.00648	CcSEcCtD
Pomalidomide—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.00205	0.00645	CcSEcCtD
Pomalidomide—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.00205	0.00645	CcSEcCtD
Pomalidomide—Anaemia—Colchicine—primary biliary cirrhosis	0.00205	0.00644	CcSEcCtD
Pomalidomide—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.00199	0.00626	CcSEcCtD
Pomalidomide—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.00199	0.00626	CcSEcCtD
Pomalidomide—Leukopenia—Colchicine—primary biliary cirrhosis	0.00198	0.00624	CcSEcCtD
Pomalidomide—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00193	0.00605	CcSEcCtD
Pomalidomide—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00193	0.00605	CcSEcCtD
Pomalidomide—Muscle spasms—Chenodeoxycholic acid—primary biliary cirrhosis	0.00191	0.00602	CcSEcCtD
Pomalidomide—Muscle spasms—Ursodeoxycholic acid—primary biliary cirrhosis	0.00191	0.00602	CcSEcCtD
Pomalidomide—Arthralgia—Colchicine—primary biliary cirrhosis	0.00189	0.00593	CcSEcCtD
Pomalidomide—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00184	0.00578	CcSEcCtD
Pomalidomide—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00184	0.00578	CcSEcCtD
Pomalidomide—Vertigo—Ursodeoxycholic acid—primary biliary cirrhosis	0.00179	0.00562	CcSEcCtD
Pomalidomide—Vertigo—Chenodeoxycholic acid—primary biliary cirrhosis	0.00179	0.00562	CcSEcCtD
Pomalidomide—Leukopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00178	0.0056	CcSEcCtD
Pomalidomide—Leukopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00178	0.0056	CcSEcCtD
Pomalidomide—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.00177	0.00558	CcSEcCtD
Pomalidomide—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.00177	0.00557	CcSEcCtD
Pomalidomide—Skin disorder—Colchicine—primary biliary cirrhosis	0.00176	0.00552	CcSEcCtD
Pomalidomide—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.00174	0.00546	CcSEcCtD
Pomalidomide—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.00174	0.00546	CcSEcCtD
Pomalidomide—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00169	0.00533	CcSEcCtD
Pomalidomide—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00169	0.00533	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00168	0.00529	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00168	0.00529	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.00165	0.00518	CcSEcCtD
Pomalidomide—Confusional state—Ursodeoxycholic acid—primary biliary cirrhosis	0.00164	0.00515	CcSEcCtD
Pomalidomide—Confusional state—Chenodeoxycholic acid—primary biliary cirrhosis	0.00164	0.00515	CcSEcCtD
Pomalidomide—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00161	0.00507	CcSEcCtD
Pomalidomide—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00161	0.00507	CcSEcCtD
Pomalidomide—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00159	0.00501	CcSEcCtD
Pomalidomide—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00159	0.00501	CcSEcCtD
Pomalidomide—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00159	0.005	CcSEcCtD
Pomalidomide—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00159	0.005	CcSEcCtD
Pomalidomide—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00158	0.00496	CcSEcCtD
Pomalidomide—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00158	0.00496	CcSEcCtD
Pomalidomide—Decreased appetite—Colchicine—primary biliary cirrhosis	0.00157	0.00494	CcSEcCtD
Pomalidomide—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00157	0.00494	CcSEcCtD
Pomalidomide—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00157	0.00494	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.00156	0.00491	CcSEcCtD
Pomalidomide—Fatigue—Colchicine—primary biliary cirrhosis	0.00156	0.0049	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00148	0.00465	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00148	0.00465	CcSEcCtD
Pomalidomide—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00147	0.00462	CcSEcCtD
Pomalidomide—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00147	0.00462	CcSEcCtD
Pomalidomide—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00145	0.00455	CcSEcCtD
Pomalidomide—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00145	0.00455	CcSEcCtD
Pomalidomide—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.00141	0.00444	CcSEcCtD
Pomalidomide—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.00141	0.00444	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.0014	0.00441	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.0014	0.00441	CcSEcCtD
Pomalidomide—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.0014	0.0044	CcSEcCtD
Pomalidomide—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.0014	0.0044	CcSEcCtD
Pomalidomide—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00139	0.00437	CcSEcCtD
Pomalidomide—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00139	0.00437	CcSEcCtD
Pomalidomide—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00139	0.00437	CcSEcCtD
Pomalidomide—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00139	0.00437	CcSEcCtD
Pomalidomide—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00134	0.00421	CcSEcCtD
Pomalidomide—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00134	0.00421	CcSEcCtD
Pomalidomide—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.00133	0.00419	CcSEcCtD
Pomalidomide—TNF—Ceramide signaling pathway—TNFRSF1A—primary biliary cirrhosis	0.00132	0.00534	CbGpPWpGaD
Pomalidomide—PTGS2—Eicosanoid Synthesis—GGT1—primary biliary cirrhosis	0.00132	0.00534	CbGpPWpGaD
Pomalidomide—Asthenia—Colchicine—primary biliary cirrhosis	0.0013	0.00408	CcSEcCtD
Pomalidomide—CYP1A2—Tryptophan metabolism—OGDH—primary biliary cirrhosis	0.00129	0.00522	CbGpPWpGaD
Pomalidomide—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00128	0.00404	CcSEcCtD
Pomalidomide—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00128	0.00404	CcSEcCtD
Pomalidomide—TNF—TNF receptor signaling pathway —TAB1—primary biliary cirrhosis	0.00126	0.0051	CbGpPWpGaD
Pomalidomide—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—primary biliary cirrhosis	0.00126	0.00509	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—CXCL9—primary biliary cirrhosis	0.00124	0.00501	CbGpPWpGaD
Pomalidomide—Diarrhoea—Colchicine—primary biliary cirrhosis	0.00124	0.00389	CcSEcCtD
Pomalidomide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.00122	0.00492	CbGpPWpGaD
Pomalidomide—CYP3A4—Irinotecan Pathway—ABCG2—primary biliary cirrhosis	0.00121	0.00489	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—IL12A—primary biliary cirrhosis	0.00121	0.00488	CbGpPWpGaD
Pomalidomide—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.0012	0.00376	CcSEcCtD
Pomalidomide—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.0012	0.00376	CcSEcCtD
Pomalidomide—ABCB1—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.00119	0.00482	CbGpPWpGaD
Pomalidomide—TNF—Cardiac Hypertrophic Response—TNFRSF1A—primary biliary cirrhosis	0.00119	0.00479	CbGpPWpGaD
Pomalidomide—TNF—Monoamine Transport—AGT—primary biliary cirrhosis	0.00118	0.00475	CbGpPWpGaD
Pomalidomide—TNF—Downstream signaling in naïve CD8+ T cells—STAT4—primary biliary cirrhosis	0.00117	0.00474	CbGpPWpGaD
Pomalidomide—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00366	CcSEcCtD
Pomalidomide—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00366	CcSEcCtD
Pomalidomide—TNF—Caspase Cascade in Apoptosis—TNFRSF1A—primary biliary cirrhosis	0.00115	0.00465	CbGpPWpGaD
Pomalidomide—Vomiting—Colchicine—primary biliary cirrhosis	0.00115	0.00361	CcSEcCtD
Pomalidomide—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.00115	0.00361	CcSEcCtD
Pomalidomide—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.00115	0.00361	CcSEcCtD
Pomalidomide—Rash—Colchicine—primary biliary cirrhosis	0.00114	0.00358	CcSEcCtD
Pomalidomide—Dermatitis—Colchicine—primary biliary cirrhosis	0.00114	0.00358	CcSEcCtD
Pomalidomide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.00114	0.00459	CbGpPWpGaD
Pomalidomide—TNF—TWEAK Signaling Pathway—CCL5—primary biliary cirrhosis	0.00113	0.00457	CbGpPWpGaD
Pomalidomide—Headache—Colchicine—primary biliary cirrhosis	0.00113	0.00356	CcSEcCtD
Pomalidomide—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00111	0.0035	CcSEcCtD
Pomalidomide—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00111	0.0035	CcSEcCtD
Pomalidomide—ABCB1—ABC-family proteins mediated transport—ABCC2—primary biliary cirrhosis	0.00109	0.00438	CbGpPWpGaD
Pomalidomide—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00338	CcSEcCtD
Pomalidomide—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00338	CcSEcCtD
Pomalidomide—Nausea—Colchicine—primary biliary cirrhosis	0.00107	0.00338	CcSEcCtD
Pomalidomide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.00107	0.0043	CbGpPWpGaD
Pomalidomide—TNF—IL27-mediated signaling events—TYK2—primary biliary cirrhosis	0.00104	0.0042	CbGpPWpGaD
Pomalidomide—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00325	CcSEcCtD
Pomalidomide—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00325	CcSEcCtD
Pomalidomide—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00322	CcSEcCtD
Pomalidomide—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00322	CcSEcCtD
Pomalidomide—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00322	CcSEcCtD
Pomalidomide—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00322	CcSEcCtD
Pomalidomide—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.00102	0.0032	CcSEcCtD
Pomalidomide—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.00102	0.0032	CcSEcCtD
Pomalidomide—TNF—Spinal Cord Injury—AQP4—primary biliary cirrhosis	0.001	0.00403	CbGpPWpGaD
Pomalidomide—CYP3A4—Tryptophan metabolism—OGDH—primary biliary cirrhosis	0.000999	0.00403	CbGpPWpGaD
Pomalidomide—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—primary biliary cirrhosis	0.000981	0.00396	CbGpPWpGaD
Pomalidomide—TNF—Signaling events mediated by HDAC Class I—TNFRSF1A—primary biliary cirrhosis	0.000978	0.00395	CbGpPWpGaD
Pomalidomide—TNF—Matrix Metalloproteinases—MMP2—primary biliary cirrhosis	0.000972	0.00392	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—CXCL9—primary biliary cirrhosis	0.00097	0.00391	CbGpPWpGaD
Pomalidomide—TNF—Vitamin B12 Metabolism—CCL5—primary biliary cirrhosis	0.00097	0.00391	CbGpPWpGaD
Pomalidomide—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000965	0.00303	CcSEcCtD
Pomalidomide—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000965	0.00303	CcSEcCtD
Pomalidomide—TNF—IL23-mediated signaling events—NOS2—primary biliary cirrhosis	0.000957	0.00386	CbGpPWpGaD
Pomalidomide—TNF—Angiopoietin receptor Tie2-mediated signaling—RPS6KB1—primary biliary cirrhosis	0.000955	0.00385	CbGpPWpGaD
Pomalidomide—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—primary biliary cirrhosis	0.000955	0.00385	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—IL12A—primary biliary cirrhosis	0.000943	0.00381	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—DAG1—primary biliary cirrhosis	0.000941	0.0038	CbGpPWpGaD
Pomalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—primary biliary cirrhosis	0.000939	0.00379	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—IL12B—primary biliary cirrhosis	0.000931	0.00376	CbGpPWpGaD
Pomalidomide—TNF—amb2 Integrin signaling—MMP2—primary biliary cirrhosis	0.000923	0.00372	CbGpPWpGaD
Pomalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—primary biliary cirrhosis	0.000913	0.00368	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—RPS6KB1—primary biliary cirrhosis	0.000911	0.00368	CbGpPWpGaD
Pomalidomide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000908	0.00366	CbGpPWpGaD
Pomalidomide—CYP1A2—Aflatoxin activation and detoxification—GGT1—primary biliary cirrhosis	0.000902	0.00364	CbGpPWpGaD
Pomalidomide—TNF—EBV LMP1 signaling—NFKB1—primary biliary cirrhosis	0.000894	0.00361	CbGpPWpGaD
Pomalidomide—TNF—Canonical NF-kappaB pathway—NFKB1—primary biliary cirrhosis	0.000894	0.00361	CbGpPWpGaD
Pomalidomide—TNF—Alzheimers Disease—TNFRSF1A—primary biliary cirrhosis	0.000888	0.00358	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—MAP3K14—primary biliary cirrhosis	0.000886	0.00358	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—CTLA4—primary biliary cirrhosis	0.000875	0.00353	CbGpPWpGaD
Pomalidomide—PTGS2—Signaling mediated by p38-alpha and p38-beta—PPARGC1A—primary biliary cirrhosis	0.000871	0.00351	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—TNFRSF1A—primary biliary cirrhosis	0.000846	0.00341	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—primary biliary cirrhosis	0.0008	0.00323	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—AQP4—primary biliary cirrhosis	0.0008	0.00323	CbGpPWpGaD
Pomalidomide—TNF—TNF alpha Signaling Pathway—TNFRSF1A—primary biliary cirrhosis	0.000786	0.00317	CbGpPWpGaD
Pomalidomide—TNF—IL23-mediated signaling events—TYK2—primary biliary cirrhosis	0.000784	0.00316	CbGpPWpGaD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—primary biliary cirrhosis	0.000781	0.00315	CbGpPWpGaD
Pomalidomide—TNF—MicroRNAs in cardiomyocyte hypertrophy—TAB1—primary biliary cirrhosis	0.00078	0.00315	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—IL4—primary biliary cirrhosis	0.000765	0.00309	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—IL12B—primary biliary cirrhosis	0.000759	0.00306	CbGpPWpGaD
Pomalidomide—TNF—Selenium Micronutrient Network—GGT1—primary biliary cirrhosis	0.000756	0.00305	CbGpPWpGaD
Pomalidomide—TNF—Transcriptional regulation of white adipocyte differentiation—PPARGC1A—primary biliary cirrhosis	0.000749	0.00302	CbGpPWpGaD
Pomalidomide—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—primary biliary cirrhosis	0.000739	0.00298	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—CXCR5—primary biliary cirrhosis	0.000736	0.00297	CbGpPWpGaD
Pomalidomide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000735	0.00297	CbGpPWpGaD
Pomalidomide—PTGS2—Arachidonic acid metabolism—GGT1—primary biliary cirrhosis	0.000735	0.00297	CbGpPWpGaD
Pomalidomide—TNF—Matrix Metalloproteinases—MMP9—primary biliary cirrhosis	0.00073	0.00295	CbGpPWpGaD
Pomalidomide—TNF—TNF alpha Signaling Pathway—TAB1—primary biliary cirrhosis	0.000726	0.00293	CbGpPWpGaD
Pomalidomide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—primary biliary cirrhosis	0.000722	0.00291	CbGpPWpGaD
Pomalidomide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000701	0.00283	CbGpPWpGaD
Pomalidomide—CYP3A4—Aflatoxin activation and detoxification—GGT1—primary biliary cirrhosis	0.000696	0.00281	CbGpPWpGaD
Pomalidomide—TNF—amb2 Integrin signaling—MMP9—primary biliary cirrhosis	0.000694	0.0028	CbGpPWpGaD
Pomalidomide—TNF—amb2 Integrin signaling—NFKB1—primary biliary cirrhosis	0.000686	0.00277	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—CD40LG—primary biliary cirrhosis	0.000681	0.00275	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IGFBP1—primary biliary cirrhosis	0.00068	0.00274	CbGpPWpGaD
Pomalidomide—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—NFKB1—primary biliary cirrhosis	0.00067	0.0027	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—CXCL9—primary biliary cirrhosis	0.000668	0.0027	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—TAB1—primary biliary cirrhosis	0.000668	0.0027	CbGpPWpGaD
Pomalidomide—ABCB1—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000663	0.00268	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—IL4—primary biliary cirrhosis	0.000662	0.00267	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL12A—primary biliary cirrhosis	0.00065	0.00262	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—CXCL10—primary biliary cirrhosis	0.000647	0.00261	CbGpPWpGaD
Pomalidomide—TNF—Angiopoietin receptor Tie2-mediated signaling—MMP2—primary biliary cirrhosis	0.000646	0.00261	CbGpPWpGaD
Pomalidomide—ABCB1—HIF-1-alpha transcription factor network—IGFBP1—primary biliary cirrhosis	0.000638	0.00258	CbGpPWpGaD
Pomalidomide—TNF—Vitamin B12 Metabolism—ALB—primary biliary cirrhosis	0.000623	0.00251	CbGpPWpGaD
Pomalidomide—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—primary biliary cirrhosis	0.00062	0.0025	CbGpPWpGaD
Pomalidomide—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—primary biliary cirrhosis	0.000619	0.0025	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—AQP4—primary biliary cirrhosis	0.000618	0.0025	CbGpPWpGaD
Pomalidomide—TNF—IL23-mediated signaling events—NFKB1—primary biliary cirrhosis	0.000611	0.00247	CbGpPWpGaD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—primary biliary cirrhosis	0.000607	0.00245	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—IL12B—primary biliary cirrhosis	0.000592	0.00239	CbGpPWpGaD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—primary biliary cirrhosis	0.00059	0.00238	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—DAG1—primary biliary cirrhosis	0.000582	0.00235	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—RPS6KA4—primary biliary cirrhosis	0.00058	0.00234	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—CXCL10—primary biliary cirrhosis	0.000576	0.00232	CbGpPWpGaD
Pomalidomide—ABCB1—HIF-1-alpha transcription factor network—ABCG2—primary biliary cirrhosis	0.000569	0.0023	CbGpPWpGaD
Pomalidomide—TNF—TWEAK Signaling Pathway—MMP9—primary biliary cirrhosis	0.000558	0.00225	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—CCL5—primary biliary cirrhosis	0.000557	0.00225	CbGpPWpGaD
Pomalidomide—TNF—TWEAK Signaling Pathway—NFKB1—primary biliary cirrhosis	0.000552	0.00223	CbGpPWpGaD
Pomalidomide—TNF—MicroRNAs in cardiomyocyte hypertrophy—AGT—primary biliary cirrhosis	0.000544	0.0022	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—TAB1—primary biliary cirrhosis	0.000522	0.0021	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—TNFRSF1A—primary biliary cirrhosis	0.000518	0.00209	CbGpPWpGaD
Pomalidomide—TNF—Aryl Hydrocarbon Receptor—NFKB1—primary biliary cirrhosis	0.000513	0.00207	CbGpPWpGaD
Pomalidomide—TNF—TNF receptor signaling pathway —NFKB1—primary biliary cirrhosis	0.000513	0.00207	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—ALB—primary biliary cirrhosis	0.000506	0.00204	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—CD80—primary biliary cirrhosis	0.000506	0.00204	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—CXCL10—primary biliary cirrhosis	0.000505	0.00204	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—primary biliary cirrhosis	0.000502	0.00203	CbGpPWpGaD
Pomalidomide—TNF—Ceramide signaling pathway—NFKB1—primary biliary cirrhosis	0.000496	0.002	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—PPARGC1A—primary biliary cirrhosis	0.000493	0.00199	CbGpPWpGaD
Pomalidomide—PTGS2—C-MYB transcription factor network—TAB1—primary biliary cirrhosis	0.000483	0.00195	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—IL4—primary biliary cirrhosis	0.00048	0.00194	CbGpPWpGaD
Pomalidomide—TNF—Angiopoietin receptor Tie2-mediated signaling—NFKB1—primary biliary cirrhosis	0.00048	0.00194	CbGpPWpGaD
Pomalidomide—TNF—Vitamin B12 Metabolism—NFKB1—primary biliary cirrhosis	0.000473	0.00191	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—GGT1—primary biliary cirrhosis	0.000468	0.00189	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—NFKB1—primary biliary cirrhosis	0.000458	0.00185	CbGpPWpGaD
Pomalidomide—TNF—TGF-beta Receptor Signaling—NFKB1—primary biliary cirrhosis	0.000452	0.00182	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—TAB1—primary biliary cirrhosis	0.000448	0.00181	CbGpPWpGaD
Pomalidomide—TNF—Cardiac Hypertrophic Response—NFKB1—primary biliary cirrhosis	0.000445	0.0018	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—TNFRSF1A—primary biliary cirrhosis	0.000438	0.00177	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—CCL5—primary biliary cirrhosis	0.000435	0.00175	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—PPARGC1A—primary biliary cirrhosis	0.000426	0.00172	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.000423	0.00171	CbGpPWpGaD
Pomalidomide—CYP1A2—Arachidonic acid metabolism—GGT1—primary biliary cirrhosis	0.000416	0.00168	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—CD80—primary biliary cirrhosis	0.000413	0.00167	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—DAG1—primary biliary cirrhosis	0.000412	0.00166	CbGpPWpGaD
Pomalidomide—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000408	0.00165	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL12B—primary biliary cirrhosis	0.000408	0.00165	CbGpPWpGaD
Pomalidomide—TNF—Selenium Micronutrient Network—ALB—primary biliary cirrhosis	0.000402	0.00162	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—HIF1A—primary biliary cirrhosis	0.000385	0.00155	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—NFKB1—primary biliary cirrhosis	0.000385	0.00155	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—AGT—primary biliary cirrhosis	0.000384	0.00155	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—CTLA4—primary biliary cirrhosis	0.000384	0.00155	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—NOS2—primary biliary cirrhosis	0.000379	0.00153	CbGpPWpGaD
Pomalidomide—TNF—Signaling events mediated by HDAC Class I—NFKB1—primary biliary cirrhosis	0.000367	0.00148	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—CXCL10—primary biliary cirrhosis	0.000356	0.00144	CbGpPWpGaD
Pomalidomide—TNF—Transcriptional regulation of white adipocyte differentiation—NFKB1—primary biliary cirrhosis	0.00034	0.00137	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—HIF1A—primary biliary cirrhosis	0.000333	0.00134	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—CD80—primary biliary cirrhosis	0.000322	0.0013	CbGpPWpGaD
Pomalidomide—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—primary biliary cirrhosis	0.000317	0.00128	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—NFKB1—primary biliary cirrhosis	0.000317	0.00128	CbGpPWpGaD
Pomalidomide—TNF—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—primary biliary cirrhosis	0.000317	0.00128	CbGpPWpGaD
Pomalidomide—TNF—Selenium Micronutrient Network—NFKB1—primary biliary cirrhosis	0.000306	0.00123	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—CD40LG—primary biliary cirrhosis	0.000298	0.0012	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL4—primary biliary cirrhosis	0.000297	0.0012	CbGpPWpGaD
Pomalidomide—TNF—TNF alpha Signaling Pathway—NFKB1—primary biliary cirrhosis	0.000295	0.00119	CbGpPWpGaD
Pomalidomide—ABCB1—HIF-1-alpha transcription factor network—HIF1A—primary biliary cirrhosis	0.00029	0.00117	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL4—primary biliary cirrhosis	0.00029	0.00117	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.000285	0.00115	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—NFKB1—primary biliary cirrhosis	0.000271	0.0011	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNFRSF1A—primary biliary cirrhosis	0.000271	0.00109	CbGpPWpGaD
Pomalidomide—CYP1A2—Phase II conjugation—GGT1—primary biliary cirrhosis	0.000265	0.00107	CbGpPWpGaD
Pomalidomide—ABCB1—HIF-1-alpha transcription factor network—NOS2—primary biliary cirrhosis	0.000264	0.00107	CbGpPWpGaD
Pomalidomide—CYP1A2—Melatonin metabolism and effects—NFKB1—primary biliary cirrhosis	0.00026	0.00105	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	0.000256	0.00103	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—ALB—primary biliary cirrhosis	0.000249	0.001	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—MMP9—primary biliary cirrhosis	0.000244	0.000986	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.000239	0.000966	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—NOS2—primary biliary cirrhosis	0.000234	0.000945	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—CD80—primary biliary cirrhosis	0.000222	0.000896	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—NFKB1—primary biliary cirrhosis	0.000212	0.000855	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—NFKB1—primary biliary cirrhosis	0.000193	0.00078	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—primary biliary cirrhosis	0.000192	0.000775	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—NFKB1—primary biliary cirrhosis	0.000189	0.000763	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—LBR—primary biliary cirrhosis	0.000188	0.00076	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—NFKB1—primary biliary cirrhosis	0.000182	0.000735	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—primary biliary cirrhosis	0.00018	0.000725	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—PPARGC1A—primary biliary cirrhosis	0.000169	0.000683	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	0.000164	0.000663	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—GGT1—primary biliary cirrhosis	0.000155	0.000625	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—MMP9—primary biliary cirrhosis	0.000151	0.00061	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	0.000145	0.000585	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—OGDH—primary biliary cirrhosis	0.000136	0.00055	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—LBR—primary biliary cirrhosis	0.000134	0.000539	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	0.000123	0.000496	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PDHX—primary biliary cirrhosis	0.000121	0.00049	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—GGT1—primary biliary cirrhosis	0.00012	0.000482	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	0.000118	0.000478	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ABCB4—primary biliary cirrhosis	0.000114	0.000461	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—DLAT—primary biliary cirrhosis	0.000114	0.000461	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	0.000114	0.000458	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—LBR—primary biliary cirrhosis	0.000107	0.00043	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	0.000105	0.000424	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	0.000104	0.000419	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—MMP2—primary biliary cirrhosis	0.000103	0.000417	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	0.000102	0.00041	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—TYK2—primary biliary cirrhosis	9.86e-05	0.000398	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—OGDH—primary biliary cirrhosis	9.65e-05	0.00039	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	9.65e-05	0.000389	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—ELMO1—primary biliary cirrhosis	9.56e-05	0.000386	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	9.35e-05	0.000377	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PDHX—primary biliary cirrhosis	8.61e-05	0.000347	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	8.23e-05	0.000332	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NUP210—primary biliary cirrhosis	8.19e-05	0.000331	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—DLAT—primary biliary cirrhosis	8.09e-05	0.000327	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ABCB4—primary biliary cirrhosis	8.09e-05	0.000327	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—MMP9—primary biliary cirrhosis	7.77e-05	0.000313	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—OGDH—primary biliary cirrhosis	7.71e-05	0.000311	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—NFKB1—primary biliary cirrhosis	7.68e-05	0.00031	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	7.28e-05	0.000294	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	7.21e-05	0.000291	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	6.95e-05	0.000281	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PDHX—primary biliary cirrhosis	6.87e-05	0.000277	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NUP210—primary biliary cirrhosis	6.86e-05	0.000277	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—GOT2—primary biliary cirrhosis	6.47e-05	0.000261	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ABCB4—primary biliary cirrhosis	6.46e-05	0.000261	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—DLAT—primary biliary cirrhosis	6.46e-05	0.000261	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ABCG2—primary biliary cirrhosis	6.38e-05	0.000257	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	5.95e-05	0.00024	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	5.95e-05	0.00024	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	5.59e-05	0.000226	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—GOT1—primary biliary cirrhosis	5.59e-05	0.000226	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CTGF—primary biliary cirrhosis	5.47e-05	0.000221	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GOT2—primary biliary cirrhosis	5.42e-05	0.000219	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	5.3e-05	0.000214	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	5.29e-05	0.000214	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	4.98e-05	0.000201	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	4.98e-05	0.000201	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NUP210—primary biliary cirrhosis	4.86e-05	0.000196	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GGT1—primary biliary cirrhosis	4.68e-05	0.000189	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GOT1—primary biliary cirrhosis	4.68e-05	0.000189	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ABCG2—primary biliary cirrhosis	4.52e-05	0.000182	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PPARGC1A—primary biliary cirrhosis	4.17e-05	0.000168	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	4.12e-05	0.000166	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—HIF1A—primary biliary cirrhosis	3.89e-05	0.000157	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NUP210—primary biliary cirrhosis	3.88e-05	0.000157	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CTGF—primary biliary cirrhosis	3.88e-05	0.000157	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GOT2—primary biliary cirrhosis	3.84e-05	0.000155	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	3.77e-05	0.000152	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ABCG2—primary biliary cirrhosis	3.61e-05	0.000146	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOS2—primary biliary cirrhosis	3.54e-05	0.000143	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CD80—primary biliary cirrhosis	3.43e-05	0.000138	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GGT1—primary biliary cirrhosis	3.32e-05	0.000134	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GOT1—primary biliary cirrhosis	3.32e-05	0.000134	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—AGT—primary biliary cirrhosis	3.24e-05	0.000131	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	3.16e-05	0.000128	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CTGF—primary biliary cirrhosis	3.1e-05	0.000125	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GOT2—primary biliary cirrhosis	3.07e-05	0.000124	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	3e-05	0.000121	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PPARGC1A—primary biliary cirrhosis	2.95e-05	0.000119	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TYK2—primary biliary cirrhosis	2.9e-05	0.000117	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	2.79e-05	0.000112	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GGT1—primary biliary cirrhosis	2.65e-05	0.000107	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GOT1—primary biliary cirrhosis	2.65e-05	0.000107	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ALB—primary biliary cirrhosis	2.49e-05	0.0001	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	2.39e-05	9.64e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	2.37e-05	9.56e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PPARGC1A—primary biliary cirrhosis	2.36e-05	9.51e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—AGT—primary biliary cirrhosis	2.3e-05	9.28e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	2.04e-05	8.25e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	2.04e-05	8.25e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—AGT—primary biliary cirrhosis	1.84e-05	7.41e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	1.82e-05	7.34e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ALB—primary biliary cirrhosis	1.76e-05	7.12e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	1.42e-05	5.72e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALB—primary biliary cirrhosis	1.41e-05	5.69e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	1.09e-05	4.39e-05	CbGpPWpGaD
